ArticleFrontiers in oncology2022

Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report.

Yuan Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.